Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
SPHERES : SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology, and Surveillance
Filetype[PDF-413.29 KB]


Details:
  • Description:
    Updated June 18, 2020

    A National Open Genomics Consortium for the COVID-19 Response

    CDC is leading the SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES), a new national genomics consortium to coordinate SARS-CoV-2 sequencing across the United States. Large-scale, rapid genomic sequencing of the virus that causes COVID-19 will allow public health experts to

    • Monitor important changes in the virus as it continues to circulate.

    • Gain important insights to support contact tracing.

    • Provide crucial information to aid in identifying diagnostic and therapeutic targets.

    • Advance public health research in the areas of transmission dynamics, host response, and evolution of the virus.

    With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.

    The SPHERES consortium is being led by CDC’s Advanced Molecular Detection (AMD) program, which over the past six years has invested in federal, state, and local public health laboratories to expand the use of pathogen genomics and other advanced laboratory technologies to strengthen infectious disease surveillance and outbreak response.

  • Content Notes:
    SPHERES Overview -- SPHERES Objectives -- SPHERES is a consortium of the US public health and scientific community.
  • Document Type:
  • Place as Subject:
  • Main Document Checksum:
You May Also Like: